الإسبوع العالمي للتوعية بالمضادات الحيوية - World antibiotic awareness weekAhmed Al-Abadlah
World antibiotic awareness week - 2016
الإسبوع العالمي للتوعية بالمضادات الحيوية
Gaza - Palestine.
Arabic, Antibiotic, World antibiotic awareness week, الاسبوع العالمي للتوعية ، المضادات الحيوية , د. عبد الرؤوف المناعمة, مشروع الميكروبات الإلكتروني - فلسطين
التوعية العالمية للمضادات
updated statistics about antimicrobial resistance,causes and mechanism of antimicrobial resistances, national antimicrobial policy, national antimicrobial surveillance, new delhi b metallo-lactamase-1 bacteria
الإسبوع العالمي للتوعية بالمضادات الحيوية - World antibiotic awareness weekAhmed Al-Abadlah
World antibiotic awareness week - 2016
الإسبوع العالمي للتوعية بالمضادات الحيوية
Gaza - Palestine.
Arabic, Antibiotic, World antibiotic awareness week, الاسبوع العالمي للتوعية ، المضادات الحيوية , د. عبد الرؤوف المناعمة, مشروع الميكروبات الإلكتروني - فلسطين
التوعية العالمية للمضادات
updated statistics about antimicrobial resistance,causes and mechanism of antimicrobial resistances, national antimicrobial policy, national antimicrobial surveillance, new delhi b metallo-lactamase-1 bacteria
For decades microbes, in particular bacteria, have become increasingly resistant to various antimicrobials.
The World Health Assembly’s endorsement of the Global Action Plan on Antimicrobial Resistance (AMR) in May 2015, and the Political Declaration of the High-Level Meeting of the General Assembly on AMR in September 2017, both recognize AMR as a global threat to public health.
These policy initiatives acknowledge overuse and misuse of antimicrobials as a main driver for development of resistance, as well as a need to optimize the use of antimicrobials.
The Global Action Plan on AMR sets out five strategic objectives as a blueprint for countries in developing national action plans (NAPs) on AMR:
Objective 1: Improve awareness and understanding of AMR through effective communication, education and training.
Objective 2: Strengthen the knowledge and evidence base through surveillance and research.
Objective 3: Reduce the incidence of infection through effective sanitation, hygiene and infection prevention measures.
Objective 4: Optimize the use of antimicrobial medicines in human and animal health.
Objective 5: Develop the economic case for sustainable investment that takes account of the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions.
Antimicrobial stewardship programmes optimize the use of antimicrobials, improve patient outcomes, reduce AMR and health-care-associated infections, and save health-care costs amongst others.
Today, AMS is one of three “pillars” of an integrated approach to health systems strengthening. The other two are infection prevention and control (IPC) and medicine and patient safety.
Linking all three pillars to other key components of infection management and health systems strengthening, such as AMR surveillance and adequate supply of quality assured medicines, promotes equitable and quality health care towards the goal of achieving universal health coverage
CDC has defined “Antimicrobial stewardship” as-
The right antibiotic
for the right patient,
at the right time,
with the right dose, and
the right route, causing
the least harm to the patient and future patients
Why AMSP is needed?
Antimicrobial Resistance (AMR)
Misuse and Over-use of Antimicrobials
Widespread Use of Antimicrobials in Other Sectors
Poor Antimicrobial Research
IMPLEMENTATION OF ANTIMICROBIAL STEWARDSHIP PROGRAM
Administrative Support (Leadership)
Formulating AMS Team
Infrastructure Support
Framing Antimicrobial Policy
Implementing AMS strategies
Education and Training
Should be publicly committed to the program.
Provide necessary funding and infrastructure support.
Multidisciplinary committee - responsible for framing, implementing and monitoring the compliance to antimicrobial policy of the hospital.
Led by the antimicrobial steward - infectious disease physician or infection control officer or clinical microbiologist.
Other members of AMS team - stewardship nurses
Lecture about patient safety, international safety goals and patient safety in egyptian standards in training course of Building Capacity for Quality Improvement Team for General Organization of Teaching Hospitals and Institutes.
Mechanism Antibiotic Resistance
Intrinsic (Natural)
Acquired
Chromosomal
Extra chromosomal
Intrinsic Resistance
Lack target : No cell wall; innately resistant to penicillin
2. Drug inactivation: Cephalosporinase in Klebsiella
3. Innate efflux pumps:
It is an active transport mechanism. It requires ATP.
Eg. E. coli, P. aeruginosa
Altered target sites
PBP alteration
Ribosomal target alteration
Decreased affinity by target modification
Beta-lactamase
Beta-lactamases are enzymes produced by bacteria that provide resistance to β-lactam antibiotics such as penicillins, cephamycins, and carbapenems
Major resistant Pathogen
1. PRSP- Penicillin resistant Streptococcus pneumoniae2. MRSA/ORSA- Methicillin-resistant Staphylococcus Aureus (Super bug)3. VRE -Vancomycin-Resistant Enterococci4. Carbapenem resistant pseudomonas aeruginosa5. Carbapenem resistant Carbapenem resistant 6. Extended spectrum beta-lactamase (ESBL)-producing bacteria
هذا الجزء يتحدث عن الحقن الغير الامن فى الدليل القومى المصرى لمكافحة العدوى يتحدث عن الطرق المستخدمة فى التقليل من الاصابة من استخدام السرنجات والحقن الغير امنة وكيفية تقليل الاضرار الناتجة عن الاستخدام الخاطىء وايضا سوف نتعلم الاتى :
ما هو الحقن الامن safe injection
القواعد العامة للحقن الامن
استخدام ( ادوات معقمة ) للحقن
منع تلوث ادوات الحقن
منع اصابة مقدم الخدمة
Description of the major classes of antimicrobial drug, resistant mechanisms developed by bacteria to combat the action of antimicrobials, and the control measures needed to limit this horizontal gene transfer.
Antibiotic Stewardship: A National and International ImperativePYA, P.C.
J. Michael Keegan, MD, an infectious disease specialist who leads the antibiotic stewardship team at PYA, discussed antibiotic stewardship at the South Dakota Pharmacists Association’s (SDPHA) Annual Convention in Deadwood, South Dakota.
For decades microbes, in particular bacteria, have become increasingly resistant to various antimicrobials.
The World Health Assembly’s endorsement of the Global Action Plan on Antimicrobial Resistance (AMR) in May 2015, and the Political Declaration of the High-Level Meeting of the General Assembly on AMR in September 2017, both recognize AMR as a global threat to public health.
These policy initiatives acknowledge overuse and misuse of antimicrobials as a main driver for development of resistance, as well as a need to optimize the use of antimicrobials.
The Global Action Plan on AMR sets out five strategic objectives as a blueprint for countries in developing national action plans (NAPs) on AMR:
Objective 1: Improve awareness and understanding of AMR through effective communication, education and training.
Objective 2: Strengthen the knowledge and evidence base through surveillance and research.
Objective 3: Reduce the incidence of infection through effective sanitation, hygiene and infection prevention measures.
Objective 4: Optimize the use of antimicrobial medicines in human and animal health.
Objective 5: Develop the economic case for sustainable investment that takes account of the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions.
Antimicrobial stewardship programmes optimize the use of antimicrobials, improve patient outcomes, reduce AMR and health-care-associated infections, and save health-care costs amongst others.
Today, AMS is one of three “pillars” of an integrated approach to health systems strengthening. The other two are infection prevention and control (IPC) and medicine and patient safety.
Linking all three pillars to other key components of infection management and health systems strengthening, such as AMR surveillance and adequate supply of quality assured medicines, promotes equitable and quality health care towards the goal of achieving universal health coverage
CDC has defined “Antimicrobial stewardship” as-
The right antibiotic
for the right patient,
at the right time,
with the right dose, and
the right route, causing
the least harm to the patient and future patients
Why AMSP is needed?
Antimicrobial Resistance (AMR)
Misuse and Over-use of Antimicrobials
Widespread Use of Antimicrobials in Other Sectors
Poor Antimicrobial Research
IMPLEMENTATION OF ANTIMICROBIAL STEWARDSHIP PROGRAM
Administrative Support (Leadership)
Formulating AMS Team
Infrastructure Support
Framing Antimicrobial Policy
Implementing AMS strategies
Education and Training
Should be publicly committed to the program.
Provide necessary funding and infrastructure support.
Multidisciplinary committee - responsible for framing, implementing and monitoring the compliance to antimicrobial policy of the hospital.
Led by the antimicrobial steward - infectious disease physician or infection control officer or clinical microbiologist.
Other members of AMS team - stewardship nurses
Lecture about patient safety, international safety goals and patient safety in egyptian standards in training course of Building Capacity for Quality Improvement Team for General Organization of Teaching Hospitals and Institutes.
Mechanism Antibiotic Resistance
Intrinsic (Natural)
Acquired
Chromosomal
Extra chromosomal
Intrinsic Resistance
Lack target : No cell wall; innately resistant to penicillin
2. Drug inactivation: Cephalosporinase in Klebsiella
3. Innate efflux pumps:
It is an active transport mechanism. It requires ATP.
Eg. E. coli, P. aeruginosa
Altered target sites
PBP alteration
Ribosomal target alteration
Decreased affinity by target modification
Beta-lactamase
Beta-lactamases are enzymes produced by bacteria that provide resistance to β-lactam antibiotics such as penicillins, cephamycins, and carbapenems
Major resistant Pathogen
1. PRSP- Penicillin resistant Streptococcus pneumoniae2. MRSA/ORSA- Methicillin-resistant Staphylococcus Aureus (Super bug)3. VRE -Vancomycin-Resistant Enterococci4. Carbapenem resistant pseudomonas aeruginosa5. Carbapenem resistant Carbapenem resistant 6. Extended spectrum beta-lactamase (ESBL)-producing bacteria
هذا الجزء يتحدث عن الحقن الغير الامن فى الدليل القومى المصرى لمكافحة العدوى يتحدث عن الطرق المستخدمة فى التقليل من الاصابة من استخدام السرنجات والحقن الغير امنة وكيفية تقليل الاضرار الناتجة عن الاستخدام الخاطىء وايضا سوف نتعلم الاتى :
ما هو الحقن الامن safe injection
القواعد العامة للحقن الامن
استخدام ( ادوات معقمة ) للحقن
منع تلوث ادوات الحقن
منع اصابة مقدم الخدمة
Description of the major classes of antimicrobial drug, resistant mechanisms developed by bacteria to combat the action of antimicrobials, and the control measures needed to limit this horizontal gene transfer.
Antibiotic Stewardship: A National and International ImperativePYA, P.C.
J. Michael Keegan, MD, an infectious disease specialist who leads the antibiotic stewardship team at PYA, discussed antibiotic stewardship at the South Dakota Pharmacists Association’s (SDPHA) Annual Convention in Deadwood, South Dakota.
The food systems in the era of the coronavirus (covid 19) pandemic crisis ara...Univ. of Tripoli
أعلنت منظمة الصحة العالمية أن تفشي الوباء الفيروس العالمي COVID-19، الذي يشار إليه على نطاق واسع باسم"الفيروس التاجي"هو وباء عالمي، والذي يتم الإبلاغ عن الآلاف من الإصابات والوفيات منه يوميا. سوف يقوم هذه المقال بالكشف عن الأنظمة الغذائية في عصر أزمة وباء COVID-19. وتقدم رؤى حول خصائص المكونات النشطة بيولوجيا من الأطعمة والأعشاب لدعم جهاز المناعة البشري ضد العدوى قبل مناقشة إمكانية انتقال COVID-19 من خلال السلسلة الغذائية. كما تسلط الضوء على قضايا الأمن الغذائي العالمية الناشئة بأن ثلث سكان العالم في حالة بطالة. وأخيراً، يؤكد التقرير أهمية الاستدامة في السلسلة الغذائية من أجل تجنب أو تقليل تواتر الأزمات الغذائية والصحية ذات الصلة في المستقبل.
Resolutions and decisions of regional interest adopted by the Seventy-sixth World Health Assembly and the Executive Board at its 152nd and 153rd sessions
Resolutions and decisions of regional interest adopted by the Seventy-fifth World Health Assembly and the Executive Board at its 150th and 151st sessions
More from WHO Regional Office for the Eastern Mediterranean (20)
عرض تقديمي مع الصور التوضيحية، لموضوع الإختناق (الغُصَّة) المهدد للحياة عند البالغين والأطفال والرُضّع مع توضيح أسبابه، أنواعه، خطورته وخطوات الإسعاف الأولي للضحيه المتعرض للإختناق (البالغين، الأطفال والرُضَّع)، ونبذة عن بعض إجراءات السلامه للوقاية من التعرض للإختناق.
سرطان الثدى الجزء الاول المقدمة من كتاب كل ما تريد أن تعرفه عن سرطان الثدى بدHeshamElbelkassy
فى هذا العرض سوف نستعرض كتاب كل ما تريد معرفته عن سرطان الثدى لعل الله يشفى به مريض ويكون سبيلا فى شفاء احد
وهذا العرض مأخوذ من كتاب كل ما تريد أن تعرفه عن سرطان الثدى من ضمن المشروع الخيرى لترجمة ونشر كتب السرطان الصادر من الجمعية السعودية الخيرية لمكافحة السرطان بدعم من محمد بن عبد الرحمن العقيل
عرض تقديمي لدوره تدريبيه لشرح خطوات دعم الحياة الاساسي والإنعاش القلبي الرئوي وإدارة مجرى الهواء الأساسية للأطفال والرضّع وشرح وضعية التعافي "الإفاقة" للمصاب اللاواعي،
مدعم بالصور التوضيحية، ومعتمد على أحدث التوصيات العالميه لعام 2024
عرض تقديمي مع الصور التوضيحيه حول جهاز مزيل الرجفان الخارجي الآلي مع شرح تفصيلي لخطوات إستعمال جهاز مزيل الرجفان الخارجي الآلي ضمن عملية دعم الحياة الأساسي (في الإنعاش القلبي الرئوي) للبالغين وكذلك خطوات إستخدامه مع الأطفال والرضَّع.
Glimpse of Hope
On Jan 7, 2015, Nature reported that using a series of new techniques, researchers have isolated a novel antimicrobial compound called teixobactin, which may be just the first in a new class of antibiotics. Teixobactin is safe and effective in mice and does not appear to induce antimicrobial resistance.
Conclusion: AMR has been observed to be common and rising for different major infections of international concern in EMR. Current evidence highlights the neglected burden of AMR in the region and the need to identify best the public health, infection control and clinical practice actions to effectively address this serious phenomenon.
276 articles, 15 grey literature and 25 national surveillance reports on AMR in countries of EMR published during 1995-2014.
Methods: In summer of 2015, we searched PubMed and IMEMR databases for published articles during 1995-2014, and Google scholar for country reports on resistance to 3rd generation cephalosporins, fluoroquinolones, carbapenems, and Penicillin. We included the bacterial infections of Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Streptococcus pneumoniae, Salmonella Typhi and Non-Typhi, Shigella and Neisseria gonorrhoeae in this review. We evaluated the risk of bias for studies which assessed the clinical and economic burden of AMR to the specified strains. We applied meta-analysis to summarize the effects and then grade the quality of evidence using the GRADE system.
GAIN---initiated by IDSA, Pew, Pharma---CDC was not formally asked to comment.
Included in final FDA user fee reauthorization.
; the list will be promulgated via regulation, updated every 5 years, and
Figure 1.3.
The sales of antibiotics for systemic use in out-patient care (sales on prescriptions) 1987- 2014, prescriptions/1 000 inhabitants and year, both sexes, different age groups.
The sales in 2014 decreased in all age groups.
*1987-2000 includes antibiotic sale to people aged 65-99 years. From 1999 the statistic includes antibiotic sale on Apo-Dose.